Iotrolan
Iotrolan
|
Systematic (IUPAC) name |
---|
2,4,6-triiodo-5-{N-methyl-2-[methyl({2,4,6-triiodo-3,5-bis[(1,3,4-trihydroxybutan-2-yl)carbamoyl]phenyl})carbamoyl]acetamido}-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide |
Clinical data |
---|
AHFS/Drugs.com |
International Drug Names |
---|
|
|
---|
|
|
---|
Identifiers |
---|
|
79770-24-4 Y |
---|
|
V08AB06 |
---|
PubChem |
CID 3738 |
---|
UNII |
16FL47B687 N |
---|
KEGG |
D01714 Y |
---|
ChEMBL |
CHEMBL1200555 N |
---|
Chemical data |
---|
Formula |
C37H48I6N6O18 |
---|
|
1626.23 g/mol |
---|
N (what is this?) (verify) |
---|
Iotrolan (trade name Isovist) is a radiocontrast agent, a substance used to improve the visibility of body structures on images obtained by X-ray techniques. It is particularly used to image spaces surrounding the central nervous system, such as the ventricles, after injection into the cerebrospinal fluid.[1] It can also be used to image joint spaces and in endoscopic retrograde cholangiopancreatography (ERCP).
Chemically, the substance is a dimer of triiodinated isophthalic acid derivatives.
References
|
---|
| X-ray and CT | Iodinated, Water soluble | Nephrotropic, high osmolar | |
---|
| Nephrotropic, low osmolar | |
---|
| Hepatotropic | |
---|
|
---|
| Iodinated, Water insoluble | |
---|
| Non-iodinated | |
---|
|
---|
| MRI | Paramagnetic |
Other: Ferric ammonium citrate
|
---|
| | |
---|
| Other | |
---|
|
---|
| Ultrasound | |
---|
| |
|